Overcoming therapy resistance in pancreatic cancer: challenges and emerging strategies
{{output}}
Pancreatic cancer (PC) is one of the deadliest types of cancer, with a 5-year survival rate of ∼12.5 %. It is expected to become the second leading cause of cancer-related deaths by 2030. Despite recent advances in treatment options by advent of various targe... ...